Published on Web 12/03/2008
Multinuclear NMR and Kinetic Analysis of DNA Interstrand
Cross-Link Formation
Hui Ding,† Ananya Majumdar,*,‡ Joel R. Tolman,† and Marc M. Greenberg*,†
Department of Chemistry and Biomolecular NMR Center, Johns Hopkins UniVersity,
3400 North Charles Street, Baltimore, Maryland 21218
Received October 4, 2008; E-mail: ananya@jhu.edu; mgreenberg@jhu.edu
Abstract: Recently, a phenylselenyl-modified thymidine (2) was shown to produce DNA interstrand cross-
links (ICLs) via two mechanisms. Photolysis of 2 generates 5-(2′-deoxyuridinyl)methyl radical (1), the reactive
intermediate that results from formal hydrogen atom abstraction from the thymine methyl group. This reactive
intermediate reacts with the opposing dA and is the first example of a DNA radical that produces ICLs.
Kinetic competition studies support the proposal that the rate-limiting step in ICL formation from 1 involves
rotation about the glycosidic bond and that the rate constant for this process is influenced by the flanking
sequence. Cross-links also form with the opposing dA when 2 is treated with mild oxidants that result in
the formation of an intermediate methide-like species (4). Kinetic experiments reveal that 4 reacts with
azide, a model nucleophile, via an SN2′ pathway. Previous experiments suggested that the same product
is produced via 1 or 4 but that the initially formed cross-link rearranges during the enzyme digestion and
isolation procedures. In situ product analysis by NMR using synthetic, doubly labeled duplex DNA containing
13C-2 and 15N1-dA provides definitive evidence that the kinetic ICL products formed via the radical and
oxidative pathways are the same and correspond to that arising from formal alkylation of N1-dA. Furthermore,
analysis of the thermodynamic product formed upon rearrangement indicates that the primary product
isomerizes via an associative mechanism in DNA.
their formation.11-14 Recently, we discovered a process by
Introduction
which the DNA radical 1 generated via formal hydrogen atom
DNA interstrand cross-links (ICLs) are responsible for the
cytotoxicity of a number of antitumor agents.1,2 They are also
produced via endogenous cellular lipid oxidation as well as by
exogenous bis-electrophiles.3-5 The physiological effects of this
DNA lesion family are frequently associated with their ability
to block replication and transcription as well as the difficulty
of their repair.1,6-8 Synthetically induced ICLs are also useful
in a variety of biotechnology applications. These include control
of gene expression in mammalian cells and sequence-specific
recognition of DNA at single-nucleotide resolution.9,10 The
importance of ICLs continues to spur creative approaches for
abstraction from the thymine methyl group cross-links with the
opposing dA in the duplex (Scheme 1).15,16 Although this
transformation was originally detected using photolabile syn-
thetic radical precursors (e.g., 2), the ICL was subsequently
identified in γ-irradiated DNA.17 This was the first characteriza-
tion of an ICL produced in DNA by γ-radiolysis via a radical.
ICLs are also produced from the phenyl selenide 2 under a
variety of oxidative conditions following sigmatropic rearrange-
ment of the selenoxide 3 (Scheme 1).15,18,19 This mild and rapid
method for producing ICLs has been used to develop a method
for detecting single-nucleotide polymorphisms.20 In this ap-
plication, covalent linkage between the biotinylated oligonucle-
otide probe and the target enhances selectivity by permitting
† Department of Chemistry.
‡ Biomolecular NMR Center.
(1) Noll, D. M.; Mason, T. M.; Miller, P. S. Chem. ReV. 2006, 106, 277–
301.
(11) Weng, X.; Ren, L.; Weng, L.; Huang, J.; Zhu, S.; Zhou, X.; Weng, L.
Angew. Chem., Int. Ed. 2007, 46, 8020–8023.
(12) Halila, S.; Velasco, T.; De Clercq, P.; Madder, A. Chem. Commun.
2005, 936–938.
(2) Scha¨rer, O. D. ChemBioChem. 2005, 6, 27–32.
(3) Stone, M. P.; Cho, Y.-J.; Huang, H.; Kim, H.-Y.; Kozekov, I. D.;
Kozekova, A.; Wang, H.; Minko, I. G.; Lloyd, R. S.; Harris, T. M.;
Rizzo, C. J. Acc. Chem. Res. 2008, 41, 793–804.
(4) Kozekov, I. D.; Nechev, L. V.; Moseley, M. S.; Harris, C. M.; Rizzo,
C. J.; Stone, M. P.; Harris, T. M. J. Am. Chem. Soc. 2003, 125, 50–
61.
(13) Alzeer, J.; Schärer, O. D. Nucleic Acids Res. 2006, 34, 4458–4466.
(14) Ali, M. M.; Nagatsugi, F.; Mori, K.; Nagasaki, Y.; Kataoka, K.; Sasaki,
S. Angew. Chem., Int. Ed. 2006, 45, 3136–3140.
(15) Hong, I. S.; Ding, H.; Greenberg, M. M. J. Am. Chem. Soc. 2006,
128, 485–491.
(5) Kim, H.-Y. H.; Voehler, M.; Harris, T. M.; Stone, M. P. J. Am. Chem.
Soc. 2002, 124, 9324–9325.
(16) Hong, I. S.; Greenberg, M. M. J. Am. Chem. Soc. 2005, 127, 3692–
3693.
(6) Niedernhofer, L. J.; Lalai, A. S.; Hoeijmakers, J. H. J. Cell 2005, 123,
1191–1198.
(17) Ding, H.; Greenberg, M. M. Chem. Res. Toxicol. 2007, 20, 1623–
1628.
(7) Tomasz, M.; Palom, Y. Pharmacol. Ther. 1997, 76, 73–87.
(8) Smeaton, M. B.; Hlavin, E. M.; McGregor Mason, T.; Noronha, A. M.;
Wilds, C. J.; Miller, P. S. Biochemistry 2008, 47, 9920–9930.
(9) Puri, N.; Majumdar, A.; Cuenoud, B.; Miller, P. S.; Seidman, M. M.
Biochemistry 2004, 43, 1343–1351.
(18) Hong, I. S.; Ding, H.; Greenberg, M. M. J. Am. Chem. Soc. 2006,
128, 2230–2231.
(19) Hong, I. S.; Greenberg, M. M. J. Am. Chem. Soc. 2005, 127, 10510–
10511.
(10) Grant, K. B.; Dervan, P. B. Biochemistry 1996, 35, 12313–12319.
(20) Peng, X.; Greenberg, M. M. Nucleic Acids Res. 2008, 36, e31.
9
10.1021/ja807845n CCC: $40.75
2008 American Chemical Society
J. AM. CHEM. SOC. 2008, 130, 17981–17987 17981